grant

Inhibition of cellcell actin-based motility during poxvirus infection by the kinase inhibitor Glivec [ 2009 - 2010 ]

Also known as: Inhibition of cellcell viral spread during poxvirus infection by Glivec, a drug used to treat cancer

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/571173]

Researchers: Dr Allison Marty (Principal investigator)

Brief description Although smallpox, one of the deadliest human pathogens, was eradicated in 1980, the current global climate has resulted in fears that smallpox may be used as a biological weapon. Unfortunately the smallpox vaccine poses a serious health hazard to certain people. We have shown that Glivec, a drug used to treat cancer, has potent anti-viral affects on poxvirus replication. This project will test the effectiveness of Glivec in treating smallpox in an animal model and study how it acts.

Funding Amount $AUD 92,950.64

Funding Scheme Early Career Fellowships

Notes Peter Doherty Biomedical ECF

Click to explore relationships graph
Identifiers
Viewed: [[ro.stat.viewed]]
ACN 633 798 857